选择语言

Human Carbonic Anhydrase IX / CA9 (38-414) Protein, His Tag (active enzyme, MALS verified)

用户评价
货号-规格
价格
Qty.
CA9-H5226-50ug
¥3675.00
CA9-H5226-1mg (200ug X 5)
¥23100.00
合计0件 产品金额¥ 0

产品详情

  • 分子别名(Synonym)

    CAIX,CA9,CA-IX,G250,MN,P54,58N,pMW1

  • 表达区间及表达系统(Source)

    Human Carbonic Anhydrase IX (38-414), His Tag (CA9-H5226) is expressed from human 293 cells (HEK293). It contains AA Gln 38 - Asp 414 (Accession # Q16790-1).

    Predicted N-terminus: Gln 38

    Request for sequence
  • 蛋白结构(Molecular Characterization)

    Carbonic Anhydrase IX Structure

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 41.7 kDa. The protein migrates as 45-55 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • 偶联(Conjugate)

    Unconjugated

  • 内毒素(Endotoxin)

    Less than 1.0 EU per μg by the LAL method.

  • 纯度(Purity)

    >90% as determined by SDS-PAGE.

  • 制剂(Formulation)

    Lyophilized from 0.22 μm filtered solution in 20 mM MES, 100 mM NaCl, pH6.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储(Storage)

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

数据展示

  • 电泳(SDS-PAGE)

    Carbonic Anhydrase IX SDS-PAGE

    Human Carbonic Anhydrase IX (38-414), His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

  • SEC-MALS

    Carbonic Anhydrase IX SEC-MALS

    The purity of Human Carbonic Anhydrase IX (38-414), His Tag (Cat. No. CA9-H5226) is more than 85% and the molecular weight of this protein is around 77-94 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-ELISA

     Carbonic Anhydrase IX ELISA

    Immobilized Human Carbonic Anhydrase IX (38-414), His Tag (Cat. No. CA9-H5226) at 1 μg/mL (100 μL/well) can bind Anti-Carbonic Anhydrase IX Antibody, Human IgG1 with a linear range of 0.08-5 ng/mL (QC tested).

    Protocol
  • 活性(Bioactivity)-SPR

     Carbonic Anhydrase IX SPR

    Anti-Carbonic Anhydrase IX Antibody captured on Protein A Chip can bind Human Carbonic Anhydrase IX (38-414), His Tag (Cat. No. CA9-H5226) with an affinity constant of 1.97 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • 活性(Bioactivity)

    The specific activity is >20 pmol/min/μg, as measured with 4-Nitrophenyl acetate (QC tested). One unit is defined as the amount of enzyme that hydrolyze 1.0 p mole of 4-Nitrophenyl acetate to 4-Nitrophenol per minute at pH7.5 at Room temperature.

    Protocol

用户评价
发表评论

背景介绍

Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes. CAs form a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons (or vice versa), a reversible reaction that occurs rather slowly in the absence of a catalyst. One of the functions of the enzyme in animals is to interconvert carbon dioxide and bicarbonate to maintain acid-base balance in blood and other tissues, and to help transport carbon dioxide out of tissues. The active site of most carbonic anhydrases contains a zinc ion. There are at least five distinct CA families (α, β, γ, δ and ε).
Carbonic anhydrase 9 (CA9 / CAIX) is also known as Membrane antigen MN (MN), Renal cell carcinoma-associated antigen G250, which belongs to the alpha-carbonic anhydrase family. CA9 / CAIX with an optimal activity at pH 6.49. Reversible hydration of carbon dioxide. CA IX participates in pH regulation. CA9 may be involved in the control of cell proliferation and transformation. CA-IX appears to be a novel specific biomarker for a cervical neoplasia.

前沿进展

 
药物研发进展
  • 英文全称:

    Carbonic anhydrase IX

  • 中文全称:

    碳酸酐酶IX

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    13 详情

  • 最高研发阶段:

    临床三期

联系我们
项目合作
查看更多项目
  • 产品基础信息
  • 产品详情
  • 数据展示
  • 用户评价
  • 背景介绍